Hiroshi Maruyama
Tracked across 1 events · 8 articles · First seen Aug 04, 2026 · Last active Aug 16, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Researchers at Nagoya University in Japan have developed an experimental treatment for periodontitis that selectively eliminates the keystone pathogen Porphyromonas gingivalis while preserving beneficial oral bacteria. The therapy, named near-infrared photo-antibacterial targeting therapy (NIR-PAT²), adapts…
Impact: Hiroshi Maruyama is the first author of the study, contributing to the development and validation of the therapy. His involvement may boost his research profile.
Aug 04, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Hiroshi Maruyama live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard